GUEST EDITORIAL

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months.

Already approved in those aged 18 and older in the United States, Valneva has submitted label extension applications to the FDA for IXCHIQ use in adolescents aged 12 to 17 years.

During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.

UVA researchers identify key blood biomarkers linked to SIDS, paving the way for life-saving tests to detect and prevent this leading cause of death among infants.